Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-06-16

FDA Approved: LEVOLEUCOVORIN — Original Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved Hikma Pharmaceuticals USA Inc.'s levoleucovorin as an Original Application generic; levoleucovorin is used in cancer regimens with methotrexate and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levoleucovorin (levoleucovorin)

Snippet

ORIG AP for LEVOLEUCOVORIN (LEVOLEUCOVORIN)